CIK 0001075880
- Accelerated filer
KAZIA THERAPEUTICS LTD
Sign in to watch- Ticker
- KZIA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- Operating
- Phone
- +61 298780088
- Business address
- THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
- Former names
- NOVOGEN LTD
- 4 Open-market buy 10% owner bought 10,800 shares at an average $10.01 ($108,092)
- 4 Open-market buy 10% owner bought 11,800 shares at an average $9.83 ($115,973)
- 4 Open-market buy 10% owner bought 8,000 shares at an average $9.74 ($77,952)
- 4 Open-market buy 10% owner bought 7,800 shares at an average $9.78 ($76,262)
- 4 Open-market buy 10% owner bought 7,100 shares at an average $10.13 ($71,910)
- 4 Open-market buy 10% owner bought 6,800 shares at an average $10.31 ($70,083)
- 4 Open-market buy 10% owner bought 3,400 shares at $10.07 ($34,250)
- 4 Open-market buy 10% owner bought 7,400 shares at an average $9.97 ($73,801)
- 4 Open-market buy 10% owner bought 7,400 shares at an average $9.99 ($73,916)
- 4 Open-market buy 10% owner bought 7,100 shares at an average $10.11 ($71,784)
- 4 Open-market buy 10% owner bought 6,800 shares at an average $10.08 ($68,513)
- 4 Open-market buy 10% owner bought 4,000 shares at an average $9.90 ($39,598)
- 4 Open-market buy 10% owner bought 3,000 shares at $9.79 ($29,370)
- 4 Open-market buy 10% owner bought 5,200 shares at an average $9.29 ($48,300)
- 4 Open-market buy 10% owner bought 9,200 shares at an average $9.91 ($91,188)
- 4 Open-market buy 10% owner bought 6,000 shares at $9.95 ($59,700)
- 4 Open-market buy 10% owner bought 5,607 shares at an average $9.89 ($55,444)
- 4 Open-market buy 10% owner bought 963 shares at $9.86 ($9,495)
- 4 Open-market buy 10% owner bought 3,100 shares at an average $9.81 ($30,425)
- 4 Open-market buy 10% owner bought 8,361 shares at an average $9.88 ($82,594)
Page 4 of 5 · 84 filings